Invesco Ltd. decreased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 38.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 138,968 shares of the financial services provider's stock after selling 87,684 shares during the quarter. Invesco Ltd. owned about 0.32% of Trupanion worth $5,179,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in TRUP. Quarry LP bought a new stake in Trupanion during the 4th quarter valued at approximately $39,000. PNC Financial Services Group Inc. boosted its stake in Trupanion by 11.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider's stock valued at $83,000 after purchasing an additional 235 shares during the period. Bayesian Capital Management LP bought a new stake in Trupanion during the 4th quarter valued at approximately $201,000. Eschler Asset Management LLP bought a new stake in Trupanion during the 4th quarter valued at approximately $214,000. Finally, Occudo Quantitative Strategies LP bought a new stake in Trupanion during the 4th quarter valued at approximately $227,000.
Analyst Ratings Changes
TRUP has been the subject of several recent research reports. Stifel Nicolaus upped their price target on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Cantor Fitzgerald raised Trupanion to a "hold" rating in a report on Wednesday, August 13th. Finally, Piper Sandler upped their price target on Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a report on Friday, August 8th. Three analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $54.17.
Check Out Our Latest Stock Analysis on TRUP
Trupanion Price Performance
Shares of TRUP traded down $1.16 during mid-day trading on Tuesday, reaching $45.20. The company had a trading volume of 479,147 shares, compared to its average volume of 553,317. Trupanion, Inc. has a twelve month low of $31.00 and a twelve month high of $57.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.69 and a quick ratio of 1.69. The company's 50-day moving average is $49.68 and its 200-day moving average is $44.01. The company has a market capitalization of $1.94 billion, a P/E ratio of 173.85 and a beta of 1.72.
Trupanion (NASDAQ:TRUP - Get Free Report) last issued its earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The business had revenue of $353.56 million during the quarter, compared to analysts' expectations of $346.73 million. During the same period in the prior year, the firm posted ($0.14) EPS. Trupanion's quarterly revenue was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Insiders Place Their Bets
In related news, CFO Fawwad Qureshi sold 2,800 shares of the firm's stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $45.56, for a total transaction of $127,568.00. Following the completion of the sale, the chief financial officer directly owned 6,451 shares of the company's stock, valued at $293,907.56. This trade represents a 30.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 5.42% of the stock is owned by corporate insiders.
Trupanion Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Articles

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.